Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

Iovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024

February 16, 2024

Iovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma

February 16, 2024

It will take a while for its risks to resolve.

Is Iovance Biotherapeutics Stock a Buy Now? ↗

February 08, 2024

One of the small biotech's top pipeline programs ran into a major setback.

Why Iovance Biotherapeutics Stock Is Crashing Today ↗

December 27, 2023

The potential pitfall could be dire, but the odds seem to be in the biotech's favor.

3 Opportunities for Iovance Biotherapeutics Stock, and 1 Risk ↗

February 12, 2024

Iovance shares have dropped by double digits over the past three years.

Is Iovance Biotherapeutics a Buy Before This Key FDA Decision? ↗

February 07, 2024

These biotech innovators have what it takes to soar.

A Bull Market Is Here: 2 Top Growth Stocks to Buy Hand Over Fist ↗

February 05, 2024

Focusing on its clinical trial setback could mean missing the bigger picture.

What's Next for Iovance Biotherapeutics Stock? ↗

February 04, 2024

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

January 19, 2024

2 Growth Stocks That Could Rocket 149% to 210% Higher in 2024, According to Wall Street ↗

January 08, 2024

Find out why investment bank analysts are hyperbullish for these stocks.

Iovance rebounded nicely after yesterday's drop, which came after the FDA put a clinical hold on its cancer-therapy trial.

Why Iovance Biotherapeutics Stock Popped Today ↗

December 28, 2023

Bone Biologics Corp (NASDAQ: BBLG) shares are trading higher Thursday and has been halted multiple times despite a lack of company-specific news. Here's what you need to know.

What's Going On With Bone Biologics Corp Stock? ↗

December 28, 2023

Via Benzinga

Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

December 28, 2023

Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program.

Via Benzinga

Investor Sentiment Edges Lower; Dow Jumps Over 100 Points ↗

December 28, 2023

The CNN Money Fear and Greed index showed a decline in overall market sentiment, but the index remained in the "Extreme Greed" zone on Wednesday. U.S. stocks closed higher on Wednesday, with the Dow...

Via Benzinga

Topics Stocks

Crude Oil Falls Over 1%; First Wave BioPharma Shares Spike Higher ↗

December 27, 2023

U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite moving lower on Wednesday. The Dow traded up 0.05% to 37,564.54 while the NASDAQ fell 0.04% to 15,069.30. The...

Via Benzinga

Topics Stocks

Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

December 27, 2023

Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

December 27, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 27, 2023

Via Benzinga

Gold Gains 1%; Richmond Fed Manufacturing Index Falls In December ↗

December 27, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 80 points on Wednesday. The Dow traded up 0.22% to 37,626.76 while the NASDAQ rose 0.06% to 15,084.02. The S&P...

Via Benzinga

Topics Economy Stocks

Iovance Biotherapeutics, Nio, NetEase And Other Big Stocks Moving Lower On Wednesday ↗

December 27, 2023

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 80 points on Wednesday.

Via Benzinga

Topics Stocks

FDA Slaps Clinical Hold On Iovance Biotherapeutics' Lung Cancer Study After Patient Death ↗

December 27, 2023

Wednesday, Iovance Biotherapeutics Inc (NASDAQ: IOVA) announced a clinical program update for LN-145 TIL therapy in non-

Via Benzinga

US Stocks Edge Higher; Coherus Reports FDA Approval Of UDENYCA ONBODY ↗

December 27, 2023

U.S. stocks traded slightly higher this morning, with the Dow Jones index gaining more than 20 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.08% to 37,575.13 while...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 27, 2023

Via Benzinga

Iovance Biotherapeutics Announces Clinical Program Update for LN-145 in Non-Small Cell Lung Cancer

December 27, 2023

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

December 22, 2023

Both of these pharma stocks could be big winners. But one stock screens as a better buy from a risk standpoint.

Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics? ↗

December 12, 2023

A Bull Market Is Coming: 1 Stock That Could Rocket 219% Higher in 2024, According to Wall Street ↗

December 12, 2023

There's a huge gap between what the stock market and Wall Street analysts have to say about this often-overlooked growth stock.